Devonian Health Group IncTSXV:GSDView on OTCQB
- LAST PRICE0.2000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1950/ 1
- Ask / Lots0.2000/ 58
- Open / Previous Close0.0000 / 0.2000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Devonian Health Group Inc | 29.6M | -6.6x | --- |
Cytophage Technologies Ltd | 27.4M | -0.9x | --- |
Nextleaf Solutions Ltd | 24.1M | 26.1x | --- |
Pharmather Holdings Ltd | 19.0M | -4.4x | --- |
BioNxt Solutions Inc | 42.0M | -4.9x | --- |
Avricore Health Inc | 15.5M | -22.0x | --- |
Company Information
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.
Contact Information
- Headquarters
- 360 rue des EntrepreneursMONTMAGNY, QC, Canada G5V 4T1
- Phone
- 514-248-7509
- Fax
- 450-937-6696
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.6M |
|---|---|
Revenue (TTM) | $5.0M |
Shares Outstanding | 148.2M |
Devonian Health Group Inc does not pay a dividend. | |
Beta | 1.40 |
EPS | $-0.03 |
Book Value | $0.10 |
P/E Ratio | -6.6x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -85.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
